Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
3.
Clin Exp Dermatol ; 44(3): 270-276, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29974485

RESUMEN

BACKGROUND: There are few studies in the literature correlating the ultrasonographic findings, clinical scoring systems or histological findings in morphoea after ultraviolet (UV)A1 phototherapy. AIMS: To evaluate the quantitative and morphological aspects of high-frequency ultrasonography in the treatment of plaque morphoea in response to UVA1 phototherapy, and to correlate these with clinical and histological scores. METHODS: In total, 17 patients with morphoea were studied. Initially and at study end, high-frequency ultrasonography (50 MHz) was performed on the edge of a morphoea lesion treated with UVA1 phototherapy. A quantitative and qualitative analysis of dermal features was performed and compared with the features of healthy skin. Skin biopsy specimens were obtained from lesions analysed at the beginning and end of the study, assessing dermal sclerosis and dermal inflammatory infiltrate and their distribution. RESULTS: All affected skin showed a statistically significant increase in dermal thickness and hypoechogenicity, corresponding to a reduction in dermal density by ultrasonography compared with healthy skin. Morphological evaluation identified undulations of the dermis in 11 of 17 lesions (64.7%) and in 5 healthy skin areas (29.4%) (P = 0.08), while 'yoyo' figures were identified in 8 lesions (47%) but only 1 healthy skin area (5.9%) (P = 0.02). Ultrasonographic morphological analysis highlighted an improvement in dermal hyperechogenic bands and disappearance of yoyo figures after UVA1 treatment. Histology revealed a reduction in dermal sclerosis and inflammation, although this was not statistically significant. CONCLUSIONS: Ultrasonographic pattern analysis of morphoea is a suitable technique for monitoring UVA1 phototherapy response.


Asunto(s)
Esclerodermia Localizada/diagnóstico por imagen , Esclerodermia Localizada/radioterapia , Terapia Ultravioleta/métodos , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esclerodermia Localizada/patología , Resultado del Tratamiento , Adulto Joven
4.
Clin Exp Dermatol ; 44(5): e177-e180, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30593710

RESUMEN

The clinical characteristics associated with hidradenitis suppurativa (HS) severity are poorly understood. In this study, 124 patients with HS from 6 Italian dermatology centres participated in this study. Disease severity was assessed using the Hidradenitis Suppurativa Physician's Global Assessment score (HS-PGA) and Hurley score. The impact of clinical characteristics on disease severity was assessed by logistic regression. Clinical characteristics were similar between men (n = 53) and women (n = 71). Disease severity was also similar; 75% of the patients had Hurley stage II or III disease, and > 60% had moderate, severe or very severe HS as judged by HS-PGA. Lesions were more frequent in the gluteal region in men (32.3% in men vs. 8.7% in women, P < 0.001) and more frequent on the breast in women (16.3% in women vs. 4.6% in men, P = 0.02). Obesity was associated with increased disease severity as measured by HS-PGA (OR: 3.28, 95% CI 1.55-6.95, P < 0.01) and Hurley classification (OR: 3.22, 95% CI 1.34-7.31, P < 0.01). Although severity of HS is similar between the sexes, the localization of lesions is different.


Asunto(s)
Hidradenitis Supurativa/fisiopatología , Adulto , Axila , Mama , Nalgas , Comorbilidad , Femenino , Ingle , Hidradenitis Supurativa/epidemiología , Humanos , Italia/epidemiología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Índice de Severidad de la Enfermedad , Factores Sexuales , Adulto Joven
5.
Clin Genet ; 92(6): 624-631, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28485813

RESUMEN

Classical Ehlers-Danlos syndrome (cEDS) is characterized by marked cutaneous involvement, according to the Villefranche nosology and its 2017 revision. However, the diagnostic flow-chart that prompts molecular testing is still based on experts' opinion rather than systematic published data. Here we report on 62 molecularly characterized cEDS patients with focus on skin, mucosal, facial, and articular manifestations. The major and minor Villefranche criteria, additional 11 mucocutaneous signs and 15 facial dysmorphic traits were ascertained and feature rates compared by sex and age. In our cohort, we did not observe any mandatory clinical sign. Skin hyperextensibility plus atrophic scars was the most frequent combination, whereas generalized joint hypermobility according to the Beighton score decreased with age. Skin was more commonly hyperextensible on elbows, neck, and knees. The sites more frequently affected by abnormal atrophic scarring were knees, face (especially forehead), pretibial area, and elbows. Facial dysmorphism commonly affected midface/orbital areas with epicanthal folds and infraorbital creases more commonly observed in young patients. Our findings suggest that the combination of ≥1 eye dysmorphism and facial/forehead scars may support the diagnosis in children. Minor acquired traits, such as molluscoid pseudotumors, subcutaneous spheroids, and signs of premature skin aging are equally useful in adults.


Asunto(s)
Colágeno Tipo V/genética , Síndrome de Ehlers-Danlos/genética , Anomalías del Ojo/genética , Inestabilidad de la Articulación/genética , Anomalías Cutáneas/genética , Adolescente , Adulto , Niño , Preescolar , Estudios de Cohortes , Colágeno Tipo V/metabolismo , Síndrome de Ehlers-Danlos/diagnóstico , Síndrome de Ehlers-Danlos/metabolismo , Síndrome de Ehlers-Danlos/patología , Anomalías del Ojo/diagnóstico , Anomalías del Ojo/metabolismo , Anomalías del Ojo/patología , Cara/anomalías , Femenino , Expresión Génica , Humanos , Inestabilidad de la Articulación/diagnóstico , Inestabilidad de la Articulación/metabolismo , Inestabilidad de la Articulación/patología , Articulaciones/anomalías , Articulaciones/metabolismo , Masculino , Persona de Mediana Edad , Mutación , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/metabolismo , Anomalías Cutáneas/patología
6.
Br J Dermatol ; 174(2): 380-5, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26498991

RESUMEN

BACKGROUND: Surgical excision represents the most common elective treatment for basal cell carcinoma (BCC). Several noninvasive approaches have been proposed for in vivo determination of tumour margin, in order to achieve radical removal. OBJECTIVES: To propose a new approach through the combination of dermoscopy and reflectance confocal microscopy (RCM) for lateral margin detection in BCC. METHODS: Ten patients with lesions clinically suggestive of nonpigmented BCCs with ill-defined margins were enrolled. All BCCs were dermoscopically evaluated first and the ill-defined margins were marked with a superficial cut and then inspected using RCM. RESULTS: RCM evaluation showed BCC foci beyond the presurgical marker in three out of 10 lesions. Histology confirmed the RCM results: the presence of BCC features across the cut, corresponding to two superficial BCCs and a morpheaform BCC. CONCLUSIONS: This new procedure helped to improve the identification of proper margins for surgical excision in nonpigmented BCC with clinically and dermoscopically ill-defined margins.


Asunto(s)
Carcinoma Basocelular/cirugía , Neoplasias Cutáneas/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Basocelular/diagnóstico por imagen , Carcinoma Basocelular/patología , Dermoscopía/métodos , Femenino , Humanos , Masculino , Márgenes de Escisión , Microscopía Confocal/métodos , Persona de Mediana Edad , Cuidados Preoperatorios/métodos , Neoplasias Cutáneas/diagnóstico por imagen , Neoplasias Cutáneas/patología
9.
Mol Plant Microbe Interact ; 17(8): 827-36, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15305603

RESUMEN

The genome sequence of Leifsonia xyli subsp. xyli, which causes ratoon stunting disease and affects sugarcane worldwide, was determined. The single circular chromosome of Leifsonia xyli subsp. xyli CTCB07 was 2.6 Mb in length with a GC content of 68% and 2,044 predicted open reading frames. The analysis also revealed 307 predicted pseudogenes, which is more than any bacterial plant pathogen sequenced to date. Many of these pseudogenes, if functional, would likely be involved in the degradation of plant heteropolysaccharides, uptake of free sugars, and synthesis of amino acids. Although L. xyli subsp. xyli has only been identified colonizing the xylem vessels of sugarcane, the numbers of predicted regulatory genes and sugar transporters are similar to those in free-living organisms. Some of the predicted pathogenicity genes appear to have been acquired by lateral transfer and include genes for cellulase, pectinase, wilt-inducing protein, lysozyme, and desaturase. The presence of the latter may contribute to stunting, since it is likely involved in the synthesis of abscisic acid, a hormone that arrests growth. Our findings are consistent with the nutritionally fastidious behavior exhibited by L. xyli subsp. xyli and suggest an ongoing adaptation to the restricted ecological niche it inhabits.


Asunto(s)
Actinomycetales/genética , Genoma Bacteriano , Actinomycetales/clasificación , Composición de Base , Genes Bacterianos , Datos de Secuencia Molecular , Seudogenes , Saccharum/microbiología
10.
Pharmacol Toxicol ; 88(2): 67-74, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11169164

RESUMEN

The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. Their antitumour activity against human chronic myeloid leukaemia cells was evaluated and compared with that of equimolar doses of daunorubicin. Only compound 7a, with the presence of both the pyridyl moiety bound at the ethylenic bridge in C-2 of benzimidazole and the nitro-group in the benzene ring, displays a selective antiproliferative effect against certain leukaemia cells and a good antiviral activity especially towards the Coxsackie B5 virus. However, it should be noted that, in the case of hydroxybenzyl-benzimidazole, resistance also builds up to compound 7a, the Coxsackie B5 virus developing resistance to it after about ten runs. Cytotoxicity tests show that many of these substances are well tolerated by the VERO cells. The mechanism of action is still unclear.


Asunto(s)
Antineoplásicos/farmacología , Antivirales/farmacología , Bencimidazoles/farmacología , Células Tumorales Cultivadas/efectos de los fármacos , Virus/efectos de los fármacos , Animales , Linfoma de Burkitt/tratamiento farmacológico , Linfoma de Burkitt/patología , División Celular/efectos de los fármacos , Chlorocebus aethiops , Daunorrubicina/farmacología , Relación Dosis-Respuesta a Droga , Farmacorresistencia Microbiana , Enterovirus Humano B/efectos de los fármacos , Humanos , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Leucemia Mielógena Crónica BCR-ABL Positiva/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Células Vero/efectos de los fármacos
11.
J Antimicrob Chemother ; 46(4): 541-50, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11020250

RESUMEN

Sulphimidazole (1-methyl-2((4-aminophenyl)-sulphonyl)-amino-5-nitroimidazole) is a new compound in which a p-aminobenzenesulphonamide radical has been attached at position 2 of the 5-nitroimidazole ring. It possesses a useful spectrum of activity in vitro against various anaerobic microorganisms and its action against aerobic and facultative bacteria is synergically enhanced in association with trimethoprim. In the present study, we determined the cytotoxicity in vitro of sulphimidazole and trimethoprim, both alone and in combination, and analysed the viability of Vero cells and the protein content of their cell lysate in the presence of increasing concentrations of these drugs. Also, in order to verify the hypothesis that the action of sulphimidazole against aerobic and facultative bacteria is mediated by the sulphonamide component of the molecule, while that against anaerobic bacteria depends on the action of the nitro group of the 5-nitroimidazole ring, we studied the mechanism of action of the new compound both indirectly, by means of microbiological techniques, and directly, by determining its oxidoreduction potential with respect to that of metronidazole. The results show that sulphimidazole is only slightly toxic in vitro for Vero cells, either alone or in association with trimethoprim, and that the combination of the two functional groups in a single molecule not only maintains its structure-activity relationship intact but also broadens its antibacterial spectrum.


Asunto(s)
Antibacterianos , Clostridium/efectos de los fármacos , Quimioterapia Combinada/farmacología , Nitroimidazoles/farmacología , Sulfonamidas/farmacología , Trimetoprim/farmacología , Animales , Chlorocebus aethiops , Quimioterapia Combinada/metabolismo , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Nitroimidazoles/metabolismo , Sulfonamidas/metabolismo , Trimetoprim/metabolismo , Células Vero
12.
Anesth Analg ; 89(4): 1050-5, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10512289

RESUMEN

UNLABELLED: We investigated the changes in oxidative stress in platelets from surgical patients anesthetized with propofol. We studied 60 surgical patients (ASA physical status I and II) and 12 healthy volunteers. The patients were divided into three groups: anesthesia induced with an IV bolus dose of 4 mg/kg thiopental; anesthesia induced with an IV bolus dose of 2 mg/kg propofol; and total IV anesthesia (induction with propofol 2 mg/kg, infusion with propofol 10 mg/kg during the first 10 min, then 8 mg/kg for 10 min, and 6 mg/kg during the rest of the operation). Healthy volunteers were given an IV bolus dose of 10% fat emulsion (Intralipid). We measured the following variables in platelets: thiobarbituric acid reactive substances content, glutathione content, and glutathione peroxidase, reductase, and transferase activities. Thiopental did not modify any of the variables. Propofol decreased thiobarbituric acid reactive substances production by 25.7% and increased total glutathione content by 24.6%. The percentage of glutathione in oxidized form was 29.5% smaller in patients anesthetized with propofol. Glutathione peroxidase activity was 28.3% less, glutathione transferase was 44.5% more, and glutathione reductase was not significantly different. Intralipid had no effect on any of the variables. After infusion of propofol for 1 h, the effects were, in qualitative terms, the same as those seen after an initial bolus dose. In conclusion, our findings show that propofol has an antioxidant effect in humans. This effect may be beneficial in patients who have diseases in which free radicals play an important role. IMPLICATIONS: This study demonstrates that propofol inhibits cellular oxidative damage, measured in platelets from surgical patients. Neither thiopental nor the fat emulsion (Intralipid) showed any effect. Moreover, propofol increased the antioxidant defense of glutathione. This could be applied in the protection of tissues from ischemic damage.


Asunto(s)
Anestésicos Intravenosos/administración & dosificación , Plaquetas/efectos de los fármacos , Depuradores de Radicales Libres/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Propofol/administración & dosificación , Procedimientos Quirúrgicos Operativos , Adulto , Anestésicos Intravenosos/farmacología , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Plaquetas/enzimología , Plaquetas/metabolismo , Emulsiones Grasas Intravenosas/uso terapéutico , Femenino , Depuradores de Radicales Libres/farmacología , Glutatión/análisis , Glutatión Peroxidasa/análisis , Glutatión Reductasa/análisis , Glutatión Transferasa/análisis , Humanos , Masculino , Propofol/farmacología , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Tiopental/administración & dosificación
13.
J Am Acad Dermatol ; 37(5 Pt 2): 884-6, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9366859

RESUMEN

Reticulate acropigmentation (RA) comprises dyschromic disorders that generally have an autosomal dominant pattern of inheritance, Two main forms of RA have been described: reticulate acropigmentation of Kitamura (RAK) and reticulate acropigmentation of Dohi (RAD). We observed a 21-year-old white woman who had progressive reticulate hyper- and hypopigmentation on the volar surface of her forearms and the dorsa of her hands. Many of her relatives have similar lesions. There were no pits or breaks in the epidermal ridge pattern on the palms. A biopsy specimen revealed areas with an excess of melanin in the basal layer alternating with others in which melanin was totally absent, Electron microscopic findings in a hypermelanotic area showed an increased number of melanocytes with high metabolic activity. In the hypomelanotic areas the melanocytes were morphologically abnormal with melanosomes at the early stages of development.


Asunto(s)
Trastornos de la Pigmentación/genética , Piel/patología , Adulto , Biopsia , Femenino , Antebrazo , Mano , Humanos , Melaninas/análisis , Melanocitos/ultraestructura , Linaje , Piel/química , Pigmentación de la Piel
19.
Pharmacol Res Commun ; 18(10): 991-6, 1986 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2433701

RESUMEN

A total of 57 herpes zoster patients (28 men and 28 women) were randomly assigned to one of the following four treatments: griseofulvin, 125 mg four times daily; methisoprinol, 1 g four times daily; griseofulvin plus methisoprinol (dosage schedules as above); placebo, four times daily. Griseofulvin had no effect at all, methisoprinol both significantly accelerated drying of vesicles and reduced pain, and the combination of griseofulvin and methisoprinol turned out to be significantly more effective in reducing pain than methisoprinol alone. The present results suggest a new effective treatment for herpes zoster disease.


Asunto(s)
Griseofulvina/uso terapéutico , Herpes Zóster/tratamiento farmacológico , Inosina Pranobex/uso terapéutico , Inosina/análogos & derivados , Anciano , Interacciones Farmacológicas , Quimioterapia Combinada , Femenino , Griseofulvina/administración & dosificación , Humanos , Inosina Pranobex/administración & dosificación , Masculino , Persona de Mediana Edad , Dolor/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...